Biotech | September 17, 2021
Argenta acquires Klifovet to expand global footprint in animal health
Klifovet’s client base comprises the world’s top animal health and nutrition companies as well as many promising startups
Klifovet’s client base comprises the world’s top animal health and nutrition companies as well as many promising startups
Crosscope and KFBIO join forces to lead digital transformation for pathology in India and emerging markets
Results reinforce the well-established safety profile of Dupixent - the first-ever biologic medicine for atopic dermatitis currently approved for patients as young 6 years old
The module offers the first preclinical laboratory information system of its kind that is fully integrated into the digital pathology workflow and provides efficient pathological studies of whole slides
The project is a collaboration between IIT Delhi and AIIMS
The approval is based on a multi-centre, single-arm, open-label pivotal clinical trial
Ultreon 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using AI -
The company had announced the expected date of completion of sale and disposal of the said undertaking is 90 days from the date of signing the Definitive Agreements.
The company plans to aggressively invest in longer gestation period projects like innovation, biosimilars, vaccines, etc.
The deal is to sell one of the two business undertakings of ZAHL for a lump sum consideration of Rs. 2921 crores on a cash free and debt free basis,
Subscribe To Our Newsletter & Stay Updated
